Med Ed Report briefs: April 2012

Med Ed Report briefs: April 2012
Med Ed Report briefs: April 2012
Accredited provider Projects In Knowledge said its free iPhone/iPad apps have surpassed 100,000 downloads. The firm's 31 digital activities also include webcasts, and video and audio cases.

Publicis Touchpoint Solutions won four projects to build clinical health educator teams for pharma clients, the firm said. The teams will consist of nearly 150 clinical health educators.

Less than half—42%—of respondents said patients are informed about potential adverse events of off-label drugs when prescribed, while 23% said patients have reported AEs, according to an Irish Patients' Association survey, funded by Novartis.

The American Academy of Family Physicians (AAFP) switched event media partners for October's scientific assembly to TriStar Publishing from Ascend Media. TriStar will produce, among other products, the AAFP UpClose daily newspaper in print, digital and mobile.

Ascend Integrated Media is now the exclusive exhibit sales rep for the American Heart Association's Scientific Sessions 2012 in Los Angeles in November,
the custom media agency said.
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.